PanGIA Biotech, Inc.
Holly Magliochetti is a seasoned entrepreneur and executive with extensive experience in the biotechnology and healthcare sectors. As the Founder and CEO of the Genetics Institute of America and Grace Health Technology since February 2017, Holly has spearheaded innovative initiatives. In May 2023, Holly took on the role of Chief Executive Officer at PanGIA Biotech, focusing on developing scalable liquid biopsy technology. Previous positions include Managing Partner at Archer Capital since 2006, President at Sympta Corporation from March 2016 to December 2017, and various leadership roles at IPC Sports Corp. and IPC Medical Corp. Holly also served as President at American Diversified Medical Corp. and Atmosphere, and Vice President at Yatinoo, Inc.
This person is not in any teams
This person is not in any offices
PanGIA Biotech, Inc.
Welcome to PanGIA Biotech, a leading biotechnology company at the forefront of true liquid biopsy technology. We are dedicated to transforming disease and cancer detection through our innovative and groundbreaking solutions. With our expertise and commitment to research, we aim to make a significant impact by empowering patients and healthcare providers with powerful detection tools.